Last $36.07 USD
Change Today +1.97 / 5.78%
Volume 200.2K
KPTI On Other Exchanges
Symbol
Exchange
NASDAQ GS
Frankfurt
As of 8:10 PM 07/22/14 All times are local (Market data is delayed by at least 15 minutes).

Executive Profile*

Christopher Kirk Ph.D.

Member of Scientific Advisory Board, Karyopharm Therapeutics, Inc.
AgeTotal Calculated CompensationThis person is connected to 12 board members in 1 different organizations across 1 different industries.

See Board Relationships
----

Background*

Dr. Christopher Kirk, Ph.D. serves as Vice President of Research at Onyx Pharmaceuticals, Inc. At Proteolix, Dr. Kirk played a key role in the discovery and early development of carfilzomib. Prior to joining Proteolix, Dr. Kirk held positions in drug discovery in inflammation at Affymax, Inc. and in target discovery in inflammation and oncology at Deltagen, Inc. Dr. Kirk held numerous positions in target and drug discovery as well as preclinical development in the biotechnology ...

Read Full Background

Corporate Headquarters*

2 Mercer Road
Natick, Massachusetts 01760

United States

Phone: 508-975-4820
Fax: --

Board Members Memberships*

There is no Board Members Memberships data available.

Education*

PhD 1999
University of Michigan

Other Affiliations*

Annual Compensation*

There is no Annual Compensation data available.

Stock Options*

There is no Stock Options data available.

Total Compensation*

There is no Total Compensation data available.
*Data is at least as current as the most recent Definitive Proxy.
 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
KPTI:US $36.07 USD +1.97

COMPETITOR COMPENSATION

There is no Competitor Compensation data available.

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact KARYOPHARM THERAPEUTICS INC, please visit . Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.